Skip to main content

Diagnosis and Endovascular Treatment of Common Vascular Complications in the Post Liver Transplant Patient: A Pictorial Essay

Clinical Review

Diagnosis and Endovascular Treatment of Common Vascular Complications in the Post Liver Transplant Patient: A Pictorial Essay

You must login or register to download this PDF.
Author Information:

 Michael O’Neill, MD1, Jamie Rosenkrantz, MD2, Jason Salsamendi, MD1, Shree Venkat, MD1, Shivank Bhatia, MD1, Govindarajan Narayanan, MD1

ABSTRACT: The role of interventional radiology in the management of patients after liver transplant is ever expanding. Vascular complications after liver transplant are not infrequently encountered, and they are associated with graft loss, high morbidity, and mortality and are a major indication for repeat transplantation. Most vascular complications will develop within 3 months of transplant and should be considered in any patient with an increase in liver function tests. We discuss several of the more commonly seen complications, which include hepatic artery thrombosis and stenosis, as well as stenosis of the portal vein, hepatic veins, and inferior vena cava, and present corresponding case examples and imaging from our own experience. 

VASCULAR DISEASE MANAGEMENT 2013:10(9):E170-E178

 

Key words: stenosis, thrombosis, complications, endovascular therapy

_____________________________

Advances in the field of minimally invasive radiologic techniques have increased the importance of interventional radiology in the management of patients after liver transplant.1 Vascular complications after liver transplant are not infrequently encountered, and they are associated with graft loss, high morbidity, and mortality, and are a major indication for repeat transplantation.2 Most vascular complications will develop within 3 months of transplant and should be considered in any patient with an increase in liver function tests (LFTs).2 Complications include hepatic artery and portal vein thrombosis and stenosis, as well as stenosis of the portal vein, hepatic veins, and inferior vena cava. In addition, combinations of antiplatelet therapy and anticoagulation are often utilized in conjunction with stent placement. Issues related to post treatment management include the type and duration of anticoagulation to use and when the patient should return for routine follow-up, for which the reader is directed to the dedicated medical literature for details.

Multiple imaging modalities can be helpful in evaluating the post transplant liver. Doppler ultrasound (DUS) is the most clinically useful imaging modality in the postoperative liver transplant period due to its wide availability, lower cost, and familiarity to most clinicians. Multidetector computed tomographic angiography (MDCTA) also can be a relatively cost-effective and noninvasive technique that can characterize very accurately the hepatic arterial anatomy after transplantation with its excellent spatial resolution and fast scan times, especially for small vessels.3 Diagnostic accuracy can be further improved with maximum intensity projections (MIP) and volume rendered images.3 Lastly, digital subtraction angiography (DSA) is the gold standard for assessing patency of the hepatic artery, but it is usually reserved for cases where an interventional therapeutic procedure is necessary because of invasiveness, high cost, and potential complications.4

Any alteration of LFTs with an etiology that cannot be explained by diagnostic imaging will require a random liver biopsy to exclude rejection and/or other pathologies. Liver biopsy can be performed by a percutaneous approach, either with ultrasound guidance or blind, or with a transjugular approach.5 

Depending on the severity of the vascular complication, the patient’s comorbidities, and physiological parameters, endovascular therapies such as balloon angioplasty and/or stenting can be therapeutically employed, as discussed in more detail throughout this work. 

Portal Vein Stenosis

While vascular post-transplant complications involving the portal vein are less common than those involving the hepatic artery, portal vein complications can lead to potentially life-threatening sequelae, including graft loss. Portal vein stenosis (PVS) is reported in roughly 3% of postoperative liver transplant patients.6 Clinical signs of PVS typically include varices, splenomegaly, and ascites, all of which result from portal hypertension. 

Patency of the portal vein may be evaluated with DUS and or cross-sectional imaging. Figures 1-4 show images from a case of a 34-year-old female with a history of liver transplant in 1994 due to autoimmune hepatitis and hepatitis, who presented with upper abdominal pain. Imaging evaluation with ultrasound followed by portal angiography was undertaken. Figures 1 and 2 show evaluation of patency. 

Karakayali et al examined late onset PVS after living donor transplant in the pediatric population. They found that PVS can be asymptomatic in some cases.7 Moreover, splenomegaly and low platelet count can be important markers of PVS and early detection using these markers can prevent graft loss. 

Percutaneous transhepatic venoplasty is the first-line nonsurgical therapeutic approach for PVS as shown in Figure 3, but the portal vein can also be accessed via a transjugular approach. Multiple studies have examined the success of endovascular treatment in PVS. Shibata et al reported a success rate of 74% with a single session of balloon dilatation; the mean follow-up time was 24 months and 28% of patients suffered recurrent stenosis.8 In this study, the maximum number of dilation sessions needed to resolve the stenosis was three. Ko et al also reported a series of 9 patients who experienced early PVS following liver donor liver transplant.9 All patients were treated with transhepatic stent placement. At 66 months after placement, 6 of the 9 patients in the study demonstrated adequate stent patency. Notably, 2 post-procedural complications were reported, which included 1 case of intrahepatic pseuodaneurym and 2 cases of hemoperitoneum. Postprocedure patency may be assessed with DUS as shown in Figure 4.

Hepatic Artery Thrombosis 

Hepatic artery thrombosis (HAT) is the most common vascular complication after orthotopic liver transplantation, with an estimated incidence of between 4% and 11% in adult transplants and between 11% and 26% in the pediatric population.10-14 Patients with HAT have a 30% to 50% incidence of eventual liver failure, leading to retransplantation or death. Hence, maintaining hepatic artery patency is likely an important variable in minimizing graft loss and mortality.15 Clinically, patients will often present with elevated liver enzymes, biliary leak, cholangitis, or other signs of rejection.15 The first-line diagnostic imaging modality is DUS. A study by Vit et al found the presence of a tardus parvus waveform to be the most reliable individual indicator of hepatic artery stenosis (HAS) or HAT, with a sensitivity of 91% and specificity of 99.1%.16 Imaging features of hepatic artery thrombosis from underlying stenosis on DUS demonstrating parvus tardus spectral waveforms are seen in Figure 5. If Doppler US and/or CT is suspicious for HAT, the next step is typically an arteriogram to confirm imaging finding. Urgent thrombectomy and revascularization is currently considered the treatment of choice in cases of early diagnosis of HAT.17 Surgical thrombectomy or retransplantation may also be necessary in patients in which percutaneous techniques fail (Figure 5). In cases of very early diagnosis, selective thrombolytic therapy can be used to try to restore hepatic flow (Figures 5-6).2

Hepatic Artery Stenosis 

 Hepatic artery stenosis is seen in 5% to 11% of transplants and has up to a 65% chance of developing into HAT within 6 months.10 Most stenoses occur at or within a few centimeters of the arterial anatomosis.18 The biliary epithelium is perfused exclusively by the hepatic artery; as a result, disruption in flow as a result of a stenosis could result in hepatic artery thrombosis, hepatic infarction, biliary ischemia and necrosis, fulminant hepatic failure, sepsis, and bacteremia.3 HAS is typically diagnosed on DUS. One study by Rinaldi et al reported the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of DUS in diagnosing HAS to be 100%, 99.5%, 95%, 100%, and 99.5% respectively.3 These results were similar to two previous studies by Tamsel et al and Platt et al.19,20 

Endovascular treatment of HAS can be performed with high technical success, acceptable morbidity, reduced invasiveness when compared to traditional surgical procedures, and similar overall rates of patient survival at 5 years when compared to traditional surgical procedures.10,21-25 The need for repeat intervention is common in our experience. Therefore, periodic follow-up imaging is routine at our institution. Initial use of a stent may improve patency when compared with percutaneous transluminal angioplasty. The not infrequently observed need for reintervention is illustrated in Figure 6 where subsequent session of thrombolysis and angioplasty were partially successful but only after stent placement achieved full patency. The efficacy of this approach was recently demonstrated in a series by Denys et al, where primary stent patency at 3, 6, and 12 months was 68%, 62%, and 53%, respectively, with a standard deviation of 14% for a confidence interval of 95%. Moreover, secondary stent patency at 3, 6, and 12 months was 84%, 77%, and 60%, respectively, with a standard deviation of 22%. The authors noted that only 4 of the 13 total patients in the series had developed restenosis at 1 year.22 Therefore, in many cases primary stent placement has become an increasingly attractive option at our institution vs balloon angioplasty alone.

Inferior Vena Cava Stenosis 

Inferior vena cava stenosis (IVCS) is a rare post-transplant complication seen in approximately 1% of patients, most commonly at the superior anastomosis of the IVC.5 Clinical manifestations of IVCS include refractory ascites which may be accompanied by a pleural effusion and/or associated with renal insufficiency, lower extremity edema, and abnormal liver enzymes.5 

Transluminal angioplasty with a transfemoral approach is the treatment of choice for this complication.5,26 Venoplasty is performed with large balloon catheters due to the wide diameter of the IVC as demonstrated in Figure 7, and sequential dilatations may be necessary for long-term patency. Stenoses not responsive to angioplasty are typically treated with a metallic stent.

Hepatic Vein Stenosis  

Hepatic vein stenosis (HVS) is a major post-transplant complication, especially in patients with partial liver graft transplantation producing graft failure with a reported incidence of 1% to 4%.5,27-29 Hepatic vein stenosis leads to hepatic congestion; manifestations include refractory ascites, refractory hydrothorax, and alteration of LFTs. Hepatic vein stenosis is most frequently seen at the site of the anastomosis and is less frequently seen in the hepatic vein itself. In the presence of clinical or radiologic suspicion of HVS, selective catheterization of all hepatic veins is necessary to confirm stenosis and to measure the trans-stenotic pressure gradient. Pressure gradients greater than 3 mmHg between the hepatic vein and the right atrium are considered pathological.29 For treatment of HVS, percutaneous interventions have adequate clinical and technical success rates. The initial treatment of choice is transjugular or transfemoral angioplasty or metallic stent placement.27-29 For example, in our case of hepatic venous stenosis, a 2-year-old who had previously undergone retransplantation benefitted from a dramatic reduction of the gradient from 15 mmHg to 4 mmHg, which was achieved with venoplasty (Figure 8). Multiple interventions may be required for long-term sustained patency, including the use of endovascular stent placement.30-32 

Conclusion

Collectively, post-liver transplant vascular complications are not uncommon and require vigilant imaging and clinical follow-up to diagnose in a timely fashion. Interventional radiologists play a critical role in the endovascular and percutaneous treatment of many complications, which often do not require operative intervention to correct. Interventions include advanced imaging (angiography/venography) and pressure measurements to confirm hemodynamic significances of an abnormality, catheter-directed thrombolysis, angioplasty or venoplasty, and if required endovascular stent placement. These interventions are highly efficacious as well. Multidisciplinary collaboration and knowledge of the expected pertinent imaging findings of these treatable complications is essential, particularly in certain cases where endovascular means of treatment fail. 

Editor’s Note: Disclosure:  The authors have completed and returned the ICMJE Form for Disclosure of Potential Conflicts of Interest. The authors report no conflicts of interest related to the content of this manuscript. 

 Manuscript received April 4, 2013; provisional acceptance given May 6, 2013; final version accepted July 1, 2013. 

Address for correspondence: Michael O’Neill, MD, Jackson Memorial Hospital/University of Miami School of Medicine, Diagnostic Radiology, 1611 NW 12th Avenue, WW 279, Miami, Florida 33026, USA. Email: moneill2@med.miami.edu

References  

  1. Amesur NB, Zajko AB. Interventional radiology in liver transplantation. Liver Transpl. 2006;12(3):330-351.
  2. Miraglia, R, Maruzelli L, Caruso S, et al. Interventional radiology procedures in adult patients who underwent liver transplantation. World J Gastroenterol. 2009;15(6):684-693. 
  3. Rinaldi P, Inchingolo R, Giuliani M, et al. Hepatic artery stenosis in liver transplantation: Imaging and interventional treatment. Eur J Radiol. 2012;81(6)1110-1115. 
  4. Zheng RQ, Mao R, Ren J, et al. Contrast-enhanced ultrasound for the evaluation of hepatic artery stenosis after liver transplantation: potential role in changing the clinical algorithm. Liver Transpl. 2010;16(6):729-735. 
  5. Miraglia R, Maruzzelli L, Caruso S, et al. Interventional radiology procedures in adult patients who underwent liver transplantation. World J Gastroenterol. 2009;15(6):684-693.
  6. Lerut J, Tzakis AG, Bron K, et al. Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg. 1987;205(4):404-414.
  7. Karakayali H, Sevmis S, Boyvat F, et al. Diagnosis and treatment of late-onset portal vein stenosis after pediatric living-donor liver transplantation. Transplant Proc. 2011;43(2):601-604. 
  8. Shibata T, Itoh K, Kubo T, et al. Percutaneous transhepatic balloon dilation of portal venous stenosis in patients with living donor liver transplantation. Radiology. 2005;235(3):1078-1083.
  9. Ko GY, Sung KB, Yoon HK, Lee S. Early posttransplantation portal vein stenosis following living donor liver transplantation: percutaneous transhepatic primary stent placement. Liver Transpl. 2007;13(4):530-536.
  10. Orons PD, Sheng R, Zajiko AB. Hepatic artery stenosis in liver transplant recipients: prevalence and cholangiographic appearance of associated biliary complications. AJR Am J Roentgenol. 1995;165(5):1145-1149. 
  11. Cotroneo AR, Di Stasi C, Cina A, et al. Stent Placement in four patients with hepatic artery stenosis or thrombosis after liver transplantation. J Vasc Interv Radiol. 2002;13(6):619-623. 
  12. Uneo T, Jones G, Martin A, et al. Clinical outcomes from hepatic artery stenting in liver transplantation. Liver Transpl. 2006;12(3):422-427. 
  13. Silva MA, Jambulingam PS, Gunson BK, et al. Hepatic artery thrombosis following orthotopic liver transplantation: a 10 year experience from a single center in the United Kingdom. Liver Transpl. 2006;12(1):146-151.
  14. Stange BJ, Glanemann M, Nuessler NC, Settmacher U, Steinmuller T, Neuhaus P. Hepatic artery thrombosis after adult liver transplantation. Liver Transpl. 2003;9(6):612-620.
  15. Hamby BA, Ramirez DE, Loss GE, et al. Endovascular treatment of hepatic artery stenosis after liver transplantation. J Vasc Surg. 2013;57(4):1067-1072.
  16. Vit A, De Candia A, Como G, Del Frate C, Marzio A, Bazzocchi M. Doppler evaluation of arterial complications of adult orthotopic liver transplantation. J Clin Ultrasound. 2003;31(7):339-345. 
  17. Pinna AD, Smith CV, Furukawa H, Starzl TE, Fung JJ. Urgent revascularization of liver allografts after early hepatic artery thrombosis. Transplantation. 1996;62(11):1584-1587.
  18. Dodd GD 3rd, Memel DS, Zajiko, AB, Baron RL, Santaguida LA. Hepatic artery stenosis and thrombosis in transplant recipients: Doppler diagnosis with resistive index and systolic acceleration time. Radiology. 1994;192(3):657-661. 
  19. Tamsel S, Demirpolat G, Killi R, et al. Vascular complications after liver transplantation: evaluation with Doppler US. Abdom Imaging. 2007;32(3):339-347.
  20. Platt JF, Yutzy GG, Bude RO, Ellis JH, Rubin JM. Use of Doppler sonography for revealing hepatic artery stenosis in liver transplant recipients. AJR Am J Roentgenol. 1997;168(2):473-476. 
  21. Boyvat F, Aytekin C, Karakayali H, Haberal M. Interventional radiology in liver transplant. Exp Clin Transplant. 2008;6(2):105-112.
  22. Denys AL, Qanadli SD, Durand F, et al. Feasibility and effectiveness of using coronary stents in the treatment of hepatic artery stenosis in after orthotopic liver transplant: preliminary report. AJR Am J Roentgenol. 2002;178:1175-1179.
  23. Maruzzelli L, Miraglia R, Caruso S, et al. Percutaneous endovascular treatment of hepatic artery stenosis in adult and pediatric populations after liver transplantation. Cardiovasc Intervent Radiol. 2010;33(6):1111-1119. 
  24. Chen GH, Wang GY, Yang Y, et al. Single center experience of the therapeutic management of hepatic artery stenosis after orthotopic liver transplantation. Report of 20 cases. Eur Surg Res. 2009;42:21-27. 
  25. Jeon GS, Won JH, Wang HJ, Kim BW, Lee BM. Endovascular treatment of acute arterial complications after living-donor liver transplantation. Clin Radiol. 2008;63(10):1009-1105.
  26. Zajko AB, Sheng R, Bron K, Reyes J, Nour B, Tzakis A. Percutaneous transluminal angioplasty of venous anastomotic stenoses complicating liver transplantation: intermediate-term results. J Vasc Interv Radiol. 1994;5:121-126.
  27. Darcy MD. Management of venous outflow complications after liver transplantation. Tech Vasc Interv Radiol. 2007;10:240-245. 
  28. Ko GY, Sung KB, Yoon HK, Kim JH, Song HY, Seo TS, Lee SG. Endovascular treatment of hepatic venous outflow obstruction after living-donor liver transplantation. J Vasc Interv Radiol. 2002;13:591-599. 
  29. Kubo T, Shibata T, Itoh K, et al. Outcome of percutaneous transhepatic venoplasty for hepatic venous outflow obstruction after living donor liver transplantation. Radiology. 2006;239:285-290.
  30. Wang SL, Sze DY, Busque S, et al. Treatment of hepatic venous outflow obstruction after piggyback liver transplantation. Radiology. 2005; 236:352-359.
  31. Sabri SS, Saad WE, Schmitt TM, et al. Endovascular therapy for hepatic artery stenosis following liver transplantation. Vasc Endovasc Surg. 2011;45(5):447–452.
  32. Busuttil R, Colonna JO 2nd, Hiatt JR, et al. The first 100 liver transplants at UCLA. Ann Surg. 1987;206(4):387–399.

 

Back to Top